Gabriel A, Kuddus R H, Rao A S, Watkins W D, Gandhi C R
Thomas E. Starzl Transplantation Institute, University of Pittsburgh, PA 15213, USA.
J Hepatol. 1998 Oct;29(4):614-27. doi: 10.1016/s0168-8278(98)80157-8.
BACKGROUND/AIMS: Reactive oxygen species are mediators of various pathophysiologic events, including postischemic reperfusion injury and inflammation. Generation of reactive oxygen species and consequent organ injury are associated with increased levels of a powerful vasoconstrictor peptide endothelin-1. Current evidence suggests that actions of endothelin-1 on the contractile and fibrogenic transdifferentiated stellate cells may play a critical role in hepatic pathophysiology. The aim of this investigation was to determine whether reactive oxygen species modulate the synthesis of endothelin-1 and its receptors in stellate cells.
Primary cultures of transdifferentiated stellate cells were exposed to reactive oxygen species-generating system, hypoxanthine/xanthine oxidase, before determination of endothelin-1 and its receptors.
The treatment caused an initial decrease in ET-1 receptor density (about 30% at 30 min), followed by a significant increase over the basal level at 6 h. The increase in the receptors, which occurred specifically in the ET(B) subtype, progressed thereafter up to 24 h and was accompanied by an augmented functional response, as indicated by an enhanced endothelin-1-induced release of [3H]arachidonic acid from the prelabeled cells. Furthermore, treatment of cells for 24 h but not 30 min caused increased expression of ET(B) mRNA as determined by semi-quantitative polymerase chain reaction. The release of endothelin-1 in the culture medium was also enhanced by hypoxanthine/xanthine oxidase treatment. These effects of hypoxanthine/xanthine oxidase were inhibited by superoxide dismutase and dimethyl sulfoxide. ET-1-induced [3H]arachidonic acid release was also inhibited by the ET(B) receptor antagonist BQ788, but not by the ET(A) receptor antagonist BQ123.
These findings indicate that interactions between ET-1 and stellate cells during episodes of the generation of reactive oxygen species can be an important mechanism in the pathophysiology of hepatic disorders.
背景/目的:活性氧是多种病理生理事件的介质,包括缺血后再灌注损伤和炎症。活性氧的产生及随之而来的器官损伤与一种强大的血管收缩肽内皮素-1水平升高有关。目前的证据表明,内皮素-1对收缩性和纤维化转分化星状细胞的作用可能在肝脏病理生理学中起关键作用。本研究的目的是确定活性氧是否调节星状细胞中内皮素-1及其受体的合成。
在测定内皮素-1及其受体之前,将转分化星状细胞的原代培养物暴露于产生活性氧的系统——次黄嘌呤/黄嘌呤氧化酶。
该处理导致ET-1受体密度最初下降(30分钟时约下降30%),随后在6小时时显著高于基础水平。受体的增加特异性地发生在ET(B)亚型中,此后持续至24小时,并伴随着功能反应增强,这表现为内皮素-1诱导的预标记细胞中[3H]花生四烯酸释放增加。此外,通过半定量聚合酶链反应测定,细胞处理24小时而非30分钟导致ET(B) mRNA表达增加。次黄嘌呤/黄嘌呤氧化酶处理也增强了培养基中内皮素-1的释放。超氧化物歧化酶和二甲基亚砜抑制了次黄嘌呤/黄嘌呤氧化酶的这些作用。ET-1诱导的[3H]花生四烯酸释放也被ET(B)受体拮抗剂BQ788抑制,但未被ET(A)受体拮抗剂BQ123抑制。
这些发现表明,在活性氧产生过程中ET-1与星状细胞之间的相互作用可能是肝脏疾病病理生理学中的一个重要机制。